What happened in optometry this week: October 28 - November 1

Blog
Article

Catch up on what happened in optometry during the week of October 28-November 1.

Catch up with what Optometry Times shared this week:

CORXEL and LENZ Therapeutics announce positive topline data from China phase 3 presbyopia trial of LNZ100

By Lynda Charters

Corxel Pharmaceuticals (CORXEL) and LENZ Therapeutics released positive topline data from the phase 3 JX07001 clinical trial of LNZ100 (1.75% aceclidine HCl, a miotic) in presbyopic Chinese patients.

The phase 3 safety and efficacy results showed that the drug met the primary endpoint and key secondary endpoints, with 3 lines or more improvements in the best-corrected distance visual acuity (VA) at near and the patients maintained their optimal distance VA, defined as no loss of 5 or more letters, according to a press release.

Read more...

Contact Lens Institute releases full report on contact lens wearer retention

By Jordana Joy, Associate Editor

Following consumer data released in late September,1 the Contact Len Institute (CLI) has released the full report that detailed new and long-term soft contact users’ rates of retention. The report, entitled “Disrupting the Dropout Dilemma: Practical Steps to Keep Patients in Contact Lenses,” found that satisfaction in contact lens wear was generally high across all survey participants.2

Read here...

A model to predict iris melanoma

By Lynda Charters

Arun Singh, MD, and colleagues developed a model that provides direct diagnostic prediction of a lesion being iris melanoma.1 He is Director of the Department of Ophthalmic Oncology, Cole Eye Institute at the Cleveland Clinic, Cleveland Clinic Main Campus Hospital, Cleveland.

The investigators conducted a retrospective consecutive case series that included 100 cases of pathologically confirmed iris melanoma and 112 cases of iris naevus, with either pathological confirmation or documented stability exceeding 1 year.

Read here...

AAOpt 2024: AAO-sponsored report recommends a disease classification for myopia

By Jordana Joy, Associate Editor

The American Academy of Optometry has sponsored a National Academies of Sciences, Engineering, and Medicine (NASEM) that has recommended that the Centers for Medicare and Medicaid Services classify myopia as a disease.1 The report, entitled “Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease,” compiled from a consensus study, works to identify and assess the current mechanistic understanding of myopia pathogenesis and the causes of its increased prevalence.

Read here...

Cutting back on screen time for the sake of myopia management

By Erin Tomiyama, OD, PhD, FAAO

In an increasingly digital world, the rise of myopia has become a significant concern. Although it is easy to assume there is a direct connection between screen time and the myopia epidemic, the prevalence of myopia has been on the rise long before the increased use of screen time in children. In the early 2000s, the prevalence of myopia was almost double that in the 1970s.1 Despite this observation, myopia development is multifactorial, thus the relationship between screen time and myopia must be explored.

Read here...

Recent Videos
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
© 2024 MJH Life Sciences

All rights reserved.